These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15240746)

  • 41. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T cell avidity determines the level of CTL activation.
    Hofmann M; Radsak M; Rechtsteiner G; Wiemann K; Günder M; Bien-Gräter U; Offringa R; Toes RE; Rammensee HG; Schild H
    Eur J Immunol; 2004 Jul; 34(7):1798-806. PubMed ID: 15214028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.
    Butler MO; Lee JS; Ansén S; Neuberg D; Hodi FS; Murray AP; Drury L; Berezovskaya A; Mulligan RC; Nadler LM; Hirano N
    Clin Cancer Res; 2007 Mar; 13(6):1857-67. PubMed ID: 17363542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-15 favors the expansion of central memory CD8+ T cells in ex vivo generated, antileukemia human cytotoxic T lymphocyte lines.
    Daudt L; Maccario R; Locatelli F; Turin I; Silla L; Montini E; Percivalle E; Giugliani R; Avanzini MA; Moretta A; Montagna D
    J Immunother; 2008 May; 31(4):385-93. PubMed ID: 18391757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A single amino acid substitution improves the in vivo immunogenicity of the HPV16 oncoprotein E7(11-20) cytotoxic T lymphocyte epitope.
    Schreurs MW; Kueter EW; Scholten KB; Lemonnier FA; Meijer CJ; Hooijberg E
    Vaccine; 2005 Jul; 23(31):4005-10. PubMed ID: 15963358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation requirements, lytic mechanism, and development of a novel anti-CD8-resistant CTL population.
    McCarthy SA; Mainwaring MS; Dougall DS; Lamouse-Smith ES
    J Immunol; 1998 Mar; 160(6):2715-24. PubMed ID: 9510171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The number of long-lasting functional memory CD8+ T cells generated depends on the nature of the initial nonspecific stimulation.
    Fernando GJ; Khammanivong V; Leggatt GR; Liu WJ; Frazer IH
    Eur J Immunol; 2002 Jun; 32(6):1541-9. PubMed ID: 12115636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A partially modified retro-inverso pseudopeptide modulates the cytokine profile of CTL specific for an influenza virus epitope.
    Ostankovitch M; Guichard G; Connan F; Muller S; Chaboissier A; Hoebeke J; Choppin J; Briand JP; Guillet JG
    J Immunol; 1998 Jul; 161(1):200-8. PubMed ID: 9647225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2.
    Mochimaru H; Usui T; Yaguchi T; Nagahama Y; Hasegawa G; Usui Y; Shimmura S; Tsubota K; Amano S; Kawakami Y; Ishida S
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2172-7. PubMed ID: 18263815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion protein.
    Liu H; Wu BH; Rowse GJ; Emtage PC
    Clin Vaccine Immunol; 2007 Aug; 14(8):1013-23. PubMed ID: 17596433
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients.
    Alves PM; Viatte S; Fagerberg T; Michielin O; Bricard G; Bouzourene H; Vuilleumier H; Kruger T; Givel JC; Lévy F; Speiser DE; Cerottini JC; Romero P
    Cancer Immunol Immunother; 2007 Nov; 56(11):1795-805. PubMed ID: 17447064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense.
    Messaoudi I; Guevara Patiño JA; Dyall R; LeMaoult J; Nikolich-Zugich J
    Science; 2002 Nov; 298(5599):1797-800. PubMed ID: 12459592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variation in cytotoxic T-lymphocyte responses to peptides derived from tyrosinase-related protein-2.
    Myers CE; Dionne SO; Shakalya K; Mahadevan D; Smith MH; Lake DF
    Hum Immunol; 2008 Jan; 69(1):24-31. PubMed ID: 18295672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of an immunodominant H-2D(b)-restricted CTL epitope of human PSA.
    Pavlenko M; Leder C; Roos AK; Levitsky V; Pisa P
    Prostate; 2005 Jun; 64(1):50-9. PubMed ID: 15651071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Passive but not active CD8+ T cell-based immunotherapy interferes with liver tumor progression in a transgenic mouse model.
    Romieu R; Baratin M; Kayibanda M; Lacabanne V; Ziol M; Guillet JG; Viguier M
    J Immunol; 1998 Nov; 161(10):5133-7. PubMed ID: 9820481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High avidity CD8+ T cells generated from CD28-deficient or wildtype mice exhibit a differential dependence on lipid raft integrity for activation.
    Cawthon AG; Kroger CJ; Alexander-Miller MA
    Cell Immunol; 2004 Feb; 227(2):148-55. PubMed ID: 15135297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential avidity and cyclosporine sensitivity of committed donor-specific graft-infiltrating cytotoxic T cells and their precursors. Relevance for clinical cardiac graft rejection.
    Vaessen LM; Baan CC; Ouwehand AJ; Balk AH; Jutte NH; Mochtar B; Claas FH; Weimar W
    Transplantation; 1994 Apr; 57(7):1051-9. PubMed ID: 8165702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High avidity antigen-specific CTL identified by CD8-independent tetramer staining.
    Choi EM; Chen JL; Wooldridge L; Salio M; Lissina A; Lissin N; Hermans IF; Silk JD; Mirza F; Palmowski MJ; Dunbar PR; Jakobsen BK; Sewell AK; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5116-23. PubMed ID: 14607910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concomitant helper response rescues otherwise low avidity CD8+ memory CTLs to become efficient effectors in vivo.
    Kumaraguru U; Suvas S; Biswas PS; Azkur AK; Rouse BT
    J Immunol; 2004 Mar; 172(6):3719-24. PubMed ID: 15004176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.